• Publications
  • Influence
Development and cross-sectional validation of the Childhood Asthma Control Test.
The C-ACT is a validated tool to assess asthma control and identify children with inadequately controlled asthma and can be valuable in clinical practice and research based on its validation, ease of use, input from the child and caregiver, and alignment with asthma guidelines. Expand
International consensus on (ICON) pediatric asthma
The purpose of this document is to highlight the key messages that are common to many of the existing guidelines, while critically reviewing and commenting on any differences, thus providing a concise reference. Expand
Double-blind, placebo-controlled food challenge (DBPCFC) as an office procedure: a manual.
There is now enough experience with the use of double-blind, placebo-controlled, food challenge (DBPCFC) to recommend its use as an office procedure for most patients complaining of adverse reactionsExpand
The development and prediction of atopy in high-risk children: follow-up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance.
These findings help to elucidate the natural history of atopic disease in high-risk children, document the progression of allergy from atopic dermatitis, food allergy, and food sensitization to respiratory allergy and aeroallergen sensitization despite food allergy prevention in infancy, and identify allergy predictive markers. Expand
Construction and validation of four childhood asthma self-management scales: parent barriers, child and parent self-efficacy, and parent belief in treatment efficacy.
Four new health belief measures for asthmatic children and their parents were examined, and all measures were correlated in the hypothesized directions with health status, asthma symptoms, and impact of illness on the family. Expand
Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study.
Vitamin D insufficiency is common in this population of North American children with mild-to-moderate persistent asthma and is associated with higher odds of severe exacerbation over a 4-year period. Expand
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids.
LABA step-up was significantly more likely to provide the best response than either ICS or LTRA step- up, however, many children had a best response to ICSor LTRAstep-up therapy, highlighting the need to regularly monitor and appropriately adjust each child's asthma therapy. Expand
Long-term inhaled corticosteroids in preschool children at high risk for asthma.
In preschool children at high risk for asthma, two years of inhaled-corticosteroid therapy did not change the development of asthma symptoms or lung function during a third, treatment-free year, and these findings do not provide support for a subsequent disease-modifying effect of inhaling corticosteroids after the treatment is discontinued. Expand
Factors affecting the determination of threshold doses for allergenic foods: how much is too much?
This work sought to determine whether the quality and quantity of existing clinical data on threshold doses for commonly allergenic foods were sufficient to allow consensus to be reached on establishment ofreshold doses for specific foods. Expand
Food allergen avoidance in the prevention of food allergy in infants and children.
A review of Nutritional Committees' recommendations to prevent and treat food allergy compares, contrasts, and reconciles them, presenting the evidence that has led to their statements. Expand